Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions
Published . Updated .
FDA’s eSTAR framework raises the bar for documenting human factors and use-related risk.
Directly affected
- No company is named in this report.
Indirectly affected
- ACHC ACADIA HEALTHCARE COMPANY INC
GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ASND ASCENDIS PHARMA A/S
GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ATYR ATYR PHARMA INC COM NEW
GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- BBIO BRIDGEBIO PHARMA INC
GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- DVA DaVita HealthCare Partners, Inc.
GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- GEHC GE HEALTHCARE TECHNOLOGIES I
GA selected GEHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
FDA’s eSTAR framework raises the bar for documenting human factors and use-related risk.
Source: MedTech Dive
Price since this story was published: Acadia Healthcare (ACHC)
Since the first closing price after “Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions,” Acadia Healthcare (ACHC) is +10.34%. The S&P 500 fund (SPY) is +1.21% over the same days, a +9.13% difference versus the market.
Who reported a Acadia Healthcare (ACHC) trade near this story
- Gilbert Cisneros sell BridgeBio Pharma (BBIO) ($1,001 - $15,000). That is 15 days after publication, inside 30 days. The filing is listed beside the story “Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 3 days before publication, inside 30 days. The filing is listed beside the story “Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 42 days before publication, inside 60 days. The filing is listed beside the story “Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 46 days before publication, inside 60 days. The filing is listed beside the story “Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 46 days before publication, inside 60 days. The filing is listed beside the story “Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 53 days before publication, inside 60 days. The filing is listed beside the story “Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 55 days before publication, inside 60 days. The filing is listed beside the story “Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions.”
- Donald J Trump sell GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 59 days before publication, inside 60 days. The filing is listed beside the story “Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions.”
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Acadia Healthcare (ACHC)
Companies tied to this story
- ACHC Acadia Healthcare
Acadia Healthcare (ACHC) is linked, with no stored direction, medium confidence in the 14 Sep 2026 story “Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions.” Reason on file: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ASND Ascendis Pharma A/S
For “Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions,” Ascendis Pharma A/S (ASND) is linked, with no stored direction, medium confidence. Reason on file: GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ATYR aTYR PHARMA
In “Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions,” aTYR PHARMA (ATYR) is linked, with no stored direction, medium confidence. Reason on file: GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BBIO BridgeBio Pharma
BridgeBio Pharma (BBIO) is linked, with no stored direction, medium confidence in the 14 Sep 2026 story “Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions.” Reason on file: GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- DVA Davita
For “Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions,” Davita (DVA) is linked, with no stored direction, medium confidence. Reason on file: GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- GEHC GE HealthCare Technologies
For “Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions,” GE HealthCare Technologies (GEHC) is linked, with no stored direction, medium confidence. Reason on file: GA selected GEHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Acadia Healthcare (ACHC)
The 14 Sep 2026 story “Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions” names Acadia Healthcare (ACHC) because of this story.
For Acadia Healthcare (ACHC), the reason on file says GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Ascendis Pharma A/S (ASND) is here too. Its reason reads: GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
The price range for Acadia Healthcare (ACHC), and the dates in the story
ACHC traded between 26.75 and 32.03 across 20 sessions. The latest close on file is 30.20. ASND traded between 219.69 and 240.84 across 20 sessions. The latest close on file is 229.99. ATYR traded between 0.17 and 0.41 across 20 sessions. The latest close on file is 0.17.
How strong the case is around Acadia Healthcare (ACHC)
46 out of 100
“Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions” scores 46 out of 100. The score uses 1 sources, and 6 linked companies.